Published in J Neural Transm on January 01, 1979
Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment. Neurosci Biobehav Rev (2010) 0.96
Assessment of a new self-rating scale for post-traumatic stress disorder. Psychol Med (1997) 4.11
Gene discovery in the wood-forming tissues of poplar: analysis of 5, 692 expressed sequence tags. Proc Natl Acad Sci U S A (1998) 3.31
Neurosurgical intervention for cervical disk disease in dystonic cerebral palsy. Mov Disord (1998) 1.51
Haploidentical bone marrow transplants for haematological malignancies using non-myeloablative conditioning therapy and post-transplant immunosuppression with cyclophosphamide: results from a single Australian centre. Intern Med J (2013) 1.43
Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohorts. Eur J Neurol (2011) 1.42
Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy. Transpl Infect Dis (2010) 1.25
Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol (1997) 1.22
Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes. Intern Med J (2008) 1.19
Agmatine treatment is neuroprotective in rodent brain injury models. Life Sci (1996) 1.14
Sinistrad mirror writing and reading after brain concussion in a bi-systemic (oriento-occidental) polyglot. Cortex (1976) 1.02
Neurological features of West Nile virus infection during the 2000 outbreak in a regional hospital in Israel. J Neurol Sci (2002) 1.01
Anterior horn cell changes in a case of neurolathyrism. Acta Neuropathol (1976) 0.96
Ethyl chloride sniffing and cerebellar dysfunction (case report). Isr Ann Psychiatr Relat Discip (1979) 0.94
The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude. Mult Scler (2011) 0.93
Effect of diphenylhydantoin on the reproductive function of the male rat. J Neurol Neurosurg Psychiatry (1978) 0.92
Interleukin-1 and tumor necrosis factor receptor signaling is not required for bacteria-induced osteoclastogenesis and bone loss but is essential for protecting the host from a mixed anaerobic infection. Am J Pathol (1999) 0.91
Motor lesions in herpes zoster. Incidence and special features. Eur Neurol (1975) 0.90
Calcitonin induced increase in ACTH, beta-endorphin and cortisol secretion. Horm Metab Res (1986) 0.89
The clinical use of P300 event related potentials for the evaluation of cholinesterase inhibitors treatment in demented patients. J Neural Transm (Vienna) (2003) 0.88
Under-responsiveness of growth hormone secretion after L-dopa and deep sleep stimulation in obese subjects. Isr J Med Sci (1975) 0.87
Torsion dystonia in Israel. Ann Neurol (1980) 0.87
Accelerated recovery following polyamines and aminoguanidine treatment after facial nerve injury in rats. Brain Res (1996) 0.87
The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia. J Neural Transm (Vienna) (2001) 0.86
Presynaptic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Implications for rapid endocrine-neural interactions in stress. Life Sci (1987) 0.86
Posterior fossa lesions associated with neuropsychiatric symptomatology. Int J Neurosci (1996) 0.86
Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multi-infarct dementia. Acta Psychiatr Scand (1988) 0.86
Population genetics of the globin genes in Polynesians. Hemoglobin (1988) 0.85
Moderate nonketotic hyperglycemia--a cause of focal epilepsy. Report of two cases and review of literature. Eur Neurol (1977) 0.84
Long-term follow-up of patients with asymptomatic occlusion of the internal carotid artery with good and impaired cerebral vasomotor reactivity. Eur J Neurol (2010) 0.84
Low dose methylphenidate improves freezing in advanced Parkinson's disease during off-state. J Neural Transm Suppl (2007) 0.83
Ophthalmoplegic migraine: amelioration by Flufenamic acid, a prostaglandin inhibitor. Ophthalmologica (1977) 0.83
Transmission of spongiform encephalopathy from a familial Creutzfeldt-Jakob disease patient of Jewish Libyan origin carrying the PRNP codon 200 mutation. Neurology (1992) 0.82
Disorders of verbal expression in parkinsonism. Adv Neurol (1984) 0.82
A reduced intensity conditioning protocol associated with excellent survival in patients with myelofibrosis. Bone Marrow Transplant (2008) 0.82
A small family of novel CuZn-superoxide dismutases with high isoelectric points in hybrid aspen. Planta (2001) 0.82
The central nervous system-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS). J Neuroimmunol (2000) 0.82
Laboratory diagnosis of von Willebrand's disorder: quality and diagnostic improvements driven by peer review in a multilaboratory test process. Haemophilia (2004) 0.82
Skeletal findings in human neutrolethyrism. Is there a human osteolathyrism? Eur Neurol (1980) 0.82
Electroencephalography findings in adult patients with West Nile virus-associated meningitis and meningoencephalitis. Clin Infect Dis (2003) 0.81
High prevalence of malignant melanoma in Israeli patients with Parkinson's disease. J Neural Transm (Vienna) (2011) 0.81
Identification in Israel of 2 Jewish Creutzfeld-Jakob disease patients with a 178 mutation at their PrP gene. Acta Neurol Scand (1998) 0.81
[On the changes of certain fractions of serum glycoproteins in psoriasis]. Ann Dermatol Syphiligr (Paris) (1967) 0.81
Survival in Parkinson's disease: the effect of dementia. Parkinsonism Relat Disord (1998) 0.81
The enigma of parkinsonism in chronic borderline mercury intoxication, resolved by challenge with penicillamine. Neurotoxicology (1996) 0.81
Arginine and ornithine decarboxylation in rodent brain: coincidental changes during development and after ischemia. Neurosci Lett (1996) 0.81
Kleine-Levin syndrome with periodic apnea during hypersomnic stages--E.E.G. study. J Neural Transm (1978) 0.81
Prostaglandin--E2 levels in the saliva of common migrainous women. Headache (1983) 0.80
L-tryptophan administration in L-dopa-induced hallucinations in elderly Parkinsonian patients. Gerontology (1977) 0.80
Polysomnography in patients with intracranial tumors before and after operation. Acta Neurol Scand (2004) 0.80
Cognitive evaluation of patients with chronic neurolathyrism. Parkinsonism Relat Disord (1999) 0.80
Fludarabine-based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplants. Bone Marrow Transplant (2009) 0.80
Age-dependent loss and compensatory changes of septohippocampal cholinergic neurons in two rat strains differing in longevity and response to stress. Brain Res (1987) 0.80
Posttraumatic stress disorder in Israeli combat veterans. Effect of phenelzine treatment. Arch Gen Psychiatry (1987) 0.80
Impulsive artistic creativity as a presentation of transient cognitive alterations. Behav Med (1991) 0.80
Human neurolathyrism, a follow-up study of 200 patients. Part I: Clinical investigation. Schweiz Arch Neurol Neurochir Psychiatr (1981) 0.80
Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: eighty-month follow-up. Bone Marrow Transplant (2009) 0.79
The effect of quetiapine in psychotic Parkinsonian patients with and without dementia. An open-labeled study utilizing a structured interview. J Neurol (2005) 0.79
Sub-acute thyroiditis complicated by chorea minor. Bull Los Angeles Neurol Soc (1971) 0.79
Clomipramine and amitriptyline in the treatment of severe pain. Int J Neurosci (1979) 0.79
Penetrating injuries of the parapharyngeal space. Arch Otolaryngol (1972) 0.79
Indication to surgical management of cerebellar hemorrhage. Clin Neurol Neurosurg (1998) 0.78
Double-blind comparison of cabergoline and bromocriptine in Parkinson's disease patients with motor fluctuations. Neurology (1996) 0.78
Radiation therapy of metastatic spinal cord compression. Multidisciplinary team diagnosis and treatment. J Neurooncol (1999) 0.78
Evaluation of cholinergic treatment in demented patients by P300 evoked related potentials. Neurol Neurochir Pol (2001) 0.78
Microangiopathic hemolytic anemia in severe pre-eclampsia. A review of the literature and pathophysiology. Am J Obstet Gynecol (1974) 0.78
Painful ophthalmoplegia: the Tolosa-Hunt syndrome. Eur Neurol (1979) 0.78
EEG sleep study in parkinsonian patients under bromocryptine treatment. Eur Neurol (1978) 0.78
Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy: efficacy of the PFA-100 and vWF:CBA as combined diagnostic strategies. Haemophilia (2001) 0.78
Comparison of glatiramer acetate (Copaxone) and interferon beta-1b (Betaferon) in multiple sclerosis patients: an open-label 2-year follow-up. J Neurol Sci (2002) 0.78
Clinical and neurophysiological aspects of anatomical variants in dorsomedial hand innervation. Neurophysiol Clin (2013) 0.78
The effects of acute loading with levodopa and levodopa with selegiline on blood pressure and plasma norepinephrine levels in chronic Parkinson's disease patients. Acta Neurol Scand (2005) 0.77
Developmental regulation of the brain polyamine-stress-response. Int J Dev Neurosci (1998) 0.77
Cholinergic muscarinic binding by rat lymphocytes: effects of antagonist treatment, strain and aging. Brain Res (1986) 0.77
Cortisol, ACTH, and beta-endorphin after dexamethasone administration in Parkinson's dementia. Biol Psychiatry (1990) 0.77
Painful calf, moving foot. Mov Disord (1996) 0.77
The polyamine stress response: tissue-, endocrine-, and developmental-dependent regulation. Biochem Pharmacol (2001) 0.77
Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesia. Mov Disord (2000) 0.77
Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease. Eur J Neurol (2011) 0.77
[Dextran-40 in nonhemorrhagic cerebrovascular accidents]. Harefuah (1981) 0.77
Different effects of acute neonatal stressors and long-term postnatal handling on stress-induced changes in behavior and in ornithine decarboxylase activity of adult rats. Brain Res Dev Brain Res (2000) 0.77
Discrimination of von Willebrands disease (VWD) subtypes: direct comparison of von Willebrand factor:collagen binding assay (VWF:CBA) with monoclonal antibody (MAB) based VWF-capture systems. Thromb Haemost (2000) 0.76
Periodic lateralized epileptiform discharges in multiple sclerosis: a case report. J Clin Neurophysiol (2003) 0.76
Measurement of prostaglandin E2 in cerebrospinal fluid in patients suffering from stroke. J Neurol Neurosurg Psychiatry (1977) 0.76
EEG sleep patterns in Parkinsonian patients treated with bromocryptine and L-dopa: a comparative study. J Neural Transm (1979) 0.76
Lack of efficacy of rituximab in refractory sclerodermatous chronic GVHD. Bone Marrow Transplant (2011) 0.76
Weight loss in patients treated long-term with levodopa. Metabolic aspects. J Neurol Sci (1976) 0.75